In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Adaptive Designs: Smarter Development Programmes for Oncology
A thought leadership article by Parvin Fardipour and Alan Phillips in Pharmafocus, which reviews the different types of adaptive trial designs that have been deployed in oncology trials to good effect, and discusses how they have changed the development paradigm.
-
Stakeholder Dialogue in Europe’s Adaptive Pathways Pilot
Get insights on the how the 3 principles of EMA’s adaptive pathways have worked in practice and what to expect for future accelerated access in Europe in this Pharmaceutical Market Europe (PME) edition.
-
Challenges in Clinical Trials
Steve Cutler, outlines some of the challenges to successful clinical trials in this PharmaTimes artice.
-
Device Certification and Recertification
ICON experts Vicki Anastasi and Karen Hill outline a three-step approach in this MD+DI article to identify products with the highest commercial value, helping you prioritize your medical and IVD devices for compliance with the new MDR and IVDR.
-
Evaluation of Psoriasis Patient Attitudes in their Choice of Treatments
Psoriasis patients’ prior treatment history impacts future treatment choices. ICON’s Lina Eliasson contributes to this article.
-
Outsourcing Evolution
A thought leadership article in the International Clinical Trials by Colin Stanley on the broad spectrum of outsourcing models being deployed in the pharmaceutical industry, in particular discussing the role of Functional Service Provision (FSP) approach.
-
Four Challenges Under the New EU MDR and IVDR
This Medical Plastics News (MPN) Article authored by Vicki Anastasi and Karen Hill examines the key challenges associated with the new EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR).
-
Blockchain: The Future for Research Data Integrity?
ICON's Michel Goossens contributes insights in this Medpage Today article on the applications of blockchain technology to health research. He discusses how blockchain could eventually lead to a "paradigm shift" in which people expect their digital data, including health data, to be easily accessible, private and secure. Goossens further predicts that patients will stop asking whether or not they trust the pharmaceutical industry, or even if they trust their doctor, instead placing trust in a bigger, more secure data management system.
-
PharmaVOICE 100 Awards
PharmaVoice 100 celebrates the men and women throughout the life-sciences industry who provide inspiration to their peers, colleagues and companies through their innovative and motivational approaches to addressing the industry's myriad of challenges. ICON experts Dr. Nuala Murphy and Ramita Tandon have been recognised in the Commanders & Chiefs and Mentors categories respectively.
-
Special Report on Drug Delivery
An article featuring commentary from Peter Schueler, on the challenges of the blood-brain barrier (BBB) in CNS.
